Avidity Historical Income Statement
| RNA Stock | USD 43.03 0.30 0.69% |
Historical analysis of Avidity Biosciences income statement accounts such as Net Interest Income of 21.4 M, Interest Income of 21.4 M, Depreciation And Amortization of 2.2 M or Selling General Administrative of 56.9 M can show how well Avidity Biosciences performed in making a profits. Evaluating Avidity Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Avidity Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Avidity Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Avidity Biosciences is a good buy for the upcoming year.
Avidity |
About Avidity Income Statement Analysis
Avidity Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Avidity Biosciences shareholders. The income statement also shows Avidity investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Avidity Biosciences Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Avidity Biosciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Cost Of Revenue
Cost of Revenue is found on Avidity Biosciences income statement and represents the costs associated with goods and services Avidity Biosciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Avidity Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Avidity Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avidity Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.At present, Avidity Biosciences' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Research Development is expected to grow to about 200.5 M, whereas Total Revenue is forecasted to decline to about 6.4 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Research Development | 101.2M | 150.4M | 191.0M | 200.5M | Total Revenue | 9.3M | 9.2M | 9.6M | 6.4M |
Avidity Biosciences income statement Correlations
Click cells to compare fundamentals
Avidity Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avidity Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 7.4M | 209K | 639K | 5.7M | 6.5M | 6.9M | |
| Total Revenue | 2.3M | 6.8M | 9.3M | 9.2M | 9.6M | 6.4M | |
| Research Development | 14.5M | 37.6M | 101.2M | 150.4M | 191.0M | 200.5M | |
| Net Interest Income | (7.4M) | (3K) | 104K | 5.0M | 20.3M | 21.4M | |
| Interest Income | 161K | 206K | 104K | 5.0M | 20.3M | 21.4M | |
| Depreciation And Amortization | 348K | 373K | 639K | 1.4M | 2.1M | 2.2M | |
| Selling General Administrative | 5.1M | 13.5M | 26.2M | 37.7M | 54.2M | 56.9M | |
| Gross Profit | (12.2M) | 6.8M | 9.3M | 9.2M | 7.5M | 3.8M | |
| Other Operating Expenses | 19.7M | 51.1M | 127.4M | 188.1M | 245.2M | 257.4M | |
| Operating Income | (17.3M) | (44.3M) | (118.1M) | (178.9M) | (235.6M) | (223.8M) | |
| Net Income From Continuing Ops | (24.7M) | (44.4M) | (118.0M) | (174.0M) | (202.2M) | (192.1M) | |
| Ebit | (17.3M) | (44.3M) | (118.1M) | (178.9M) | (235.6M) | (223.8M) | |
| Ebitda | (17.0M) | (43.9M) | (117.4M) | (177.5M) | (233.5M) | (221.8M) | |
| Total Operating Expenses | 19.7M | 51.1M | 127.4M | 188.1M | 245.2M | 257.4M | |
| Reconciled Depreciation | 348K | 373K | 639K | 1.4M | 1.9M | 2.0M | |
| Income Before Tax | (24.7M) | (44.4M) | (118.0M) | (174.0M) | (212.2M) | (201.6M) | |
| Total Other Income Expense Net | (7.4M) | (78K) | 42K | 4.9M | 23.4M | 24.5M | |
| Net Income Applicable To Common Shares | (24.7M) | (44.4M) | (118.0M) | (174.0M) | (156.6M) | (148.8M) | |
| Net Income | (32.1M) | (44.0M) | (117.4M) | (169.1M) | (212.2M) | (201.6M) | |
| Income Tax Expense | 7.4M | (373K) | (639K) | (4.9M) | 1.9M | 2.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Avidity Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avidity Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avidity Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avidity Biosciences Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avidity Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. If investors know Avidity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avidity Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.88) | Revenue Per Share 0.103 | Quarterly Revenue Growth (0.17) | Return On Assets (0.18) | Return On Equity (0.28) |
The market value of Avidity Biosciences is measured differently than its book value, which is the value of Avidity that is recorded on the company's balance sheet. Investors also form their own opinion of Avidity Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Avidity Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avidity Biosciences' market value can be influenced by many factors that don't directly affect Avidity Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avidity Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avidity Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avidity Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.